Thymosin Alpha-1 Storage, Stability & Shelf Life: A Clinical Reference
HealthRX.com
No US label sets a storage temperature for thymosin alpha-1
Key numbers
- 1.6 mgDose of Zadaxin, the finished injection FDA names, authorized in some countries outside the USSource: fda.gov, as cited Nov 7, 2026
- 4 weeksLength of the first Italian-label course, given twice weekly from the first vaccinationSource: fda.gov, as cited Nov 7, 2026
- 1.8 to 2.6 hoursHalf-life of thymosin alpha-1 in healthy volunteers after subcutaneous injectionSource: fda.gov, as cited Nov 7, 2026
See the public record for Thymalfasin
At a glance
- US approval / Not FDA-approved; orphan designations are not approvals [1]
- Finished product named by FDA / Zadaxin 1.6 mg injection, authorized outside the US [1]
- Storage temperature / No US label sets one
- Reconstituted stability / No US label sets one
- Route and schedule (Italian label) / 1.6 mg subcutaneously or intramuscularly twice weekly [1]
- Half-life / about 1.8 to 2.6 hours [1]
Does thymosin alpha-1 have a labeled storage temperature?
Thymosin alpha-1 has no FDA approval, so there is no US label to set a storage temperature, expiry or beyond-use date [1]. FDA identifies Zadaxin as a finished 1.6 mg injection authorized in some countries outside the US, including Italy, India and Hong Kong [1]. Zadaxin is not interchangeable with bulk Ta1 powder [1]. The Italian label, as FDA summarized it, gives 1.6 mg subcutaneously or intramuscularly twice weekly for 4 weeks starting at the first vaccination, repeated from week 8 to week 12 [1]. It says not for children and contraindicated in pregnancy and breastfeeding, with caution in allergies, autoimmune disease and other immune-modulating drugs [1].
Questions worth asking
What the published data on this peptide cover
The clinical literature describes what Ta1 does in the body, not how it behaves on a shelf. It is thought to modulate the immune system by augmenting T-cell function [2]. After subcutaneous injection in healthy volunteers, peak levels occur at about 0.7 to 2 hours and the half-life is about 1.8 to 2.6 hours, with no accumulation after daily dosing for five days [1]. A 2001 pharmacy review gives a serum half-life of about 2 hours [2]. General protein-stability reviews describe freezing and drying stresses in lyophilization and instability in solution and the dried state [3][4]; they are general reviews of protein drugs, not thymosin alpha-1 studies.
FDA's posted concerns about the bulk substance
FDA's page on bulk substances that may raise significant safety risks when compounded lists thymosin alpha-1 in the "nominated but withdrawn" table [5]. FDA's stated concerns remain posted: significant risk of immunogenicity for certain routes of administration, peptide-impurity and characterization problems, and safety information it called inadequate to understand the extent of any safety issues [5].
Check what you know
Question 1 of 5
Score: 0 right, 0 of 5 answered
Frequently asked questions
What temperature should thymosin alpha-1 be stored at?
How long does reconstituted thymosin alpha-1 last?
Can thymosin alpha-1 be frozen?
Is Zadaxin the same as thymosin alpha-1?
References
Show all 5 referencesHide references
- U.S. Food and Drug Administration.
- Ancell CD, Phipps J, Young L. Thymosin alpha-1. Am J Health Syst Pharm. 2001;58(10):879-85; quiz 886-8.
- Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544-75.
- Wang W. Lyophilization and development of solid protein pharmaceuticals. Int J Pharm. 2000;203(1-2):1-60.
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA.